Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 2 (2005), Issue 4 (April)

1. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis.
   Aliment Pharmacol Ther, 21(7): 851-9. [Abstract] [Full-text]
2. Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
   Life Sci, 76(24): 2805-16. [Abstract] [Full-text]
3. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis.
   Diagn Microbiol Infect Dis, 51(4): 227-30. [Abstract] [Full-text]
4. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
   Hepatology, 41(4): 779-89. [Abstract] [Full-text]
5. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial.
   Hepatology, 41(4): 747-52. [Abstract] [Full-text]
6. Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis.
   Nutrition, 21(4): 480-6. [Abstract] [Full-text]
7. Persistence of liver cirrhosis in association with proliferation of nonparenchymal cells and altered location of alpha-smooth muscle actin-positive cells.
   Toxicol Pathol, 33(3): 329-35. [Abstract] [Full-text]
8. Review article: current management of renal dysfunction in the cirrhotic patient.
   Aliment Pharmacol Ther, 21(8): 949-61. [Abstract] [Full-text]
9. Serum xylosyltransferase I activity, the new biochemical fibrosis marker, is not affected by renal insufficiency.
   Clin Biochem, 38(5): 486-8. [Abstract] [Full-text]
10. Analytical variability of the Fibrotest proteins.
    Clin Biochem, 38(5): 473-8. [Abstract] [Full-text]
11. Hepatic complications of obesity.
    Gastroenterol Clin North Am, 34(1): 45-61. [Abstract] [Full-text]
12. Blockade of intrahepatic adenosine receptors improves urine excretion in cirrhotic rats induced by thioacetamide.
    J Hepatol, 42(5): 680-6. [Abstract] [Full-text]
13. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.
    J Hepatol, 42(5): 674-9. [Abstract] [Full-text]
14. Clinical significance of extrapyramidal signs in patients with cirrhosis.
    J Hepatol, 42(5): 659-65. [Abstract] [Full-text]
15. Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen.
    J Hepatol, 42(5): 652-8. [Abstract] [Full-text]
16. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Obes Surg, 15(3): 310-5. [Abstract] [Full-text]
17. Enhancement by estradiol 3-benzoate in thioacetamide-induced liver cirrhosis of rats.
    Toxicol Sci, 85(1): 720-6. [Abstract] [Full-text]
18. Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.
    Am J Physiol Gastrointest Liver Physiol, 288(5): G907-13. [Abstract] [Full-text]
19. Hepatic fibrosis: molecular mechanisms and drug targets.
    Annu Rev Pharmacol Toxicol, 45: 605-28. [Abstract] [Full-text]
20. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.
    Gut, 54(5): 718-25. [Abstract] [Full-text]
21. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.
    Gut, 54(5): 691-7. [Abstract] [Full-text]
22. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Nephrol Dial Transplant, 20(5): 920-6. [Abstract] [Full-text]
23. Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in the cerebellum and cortex of patients with liver cirrhosis.
    Neurobiol Dis, 19(1): 150-61. [Abstract] [Full-text]
24. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    J Gastroenterol Hepatol, 20(4): 599-605. [Abstract] [Full-text]
25. Colonic changes in patients with cirrhosis and in patients with extrahepatic portal vein obstruction.
    Endoscopy, 37(5): 454-9. [Abstract] [Full-text]
26. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Dig Liver Dis, 37(5): 349-56. [Abstract] [Full-text]
27. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.
    Am J Gastroenterol, 100(5): 1110-6. [Abstract] [Full-text]
28. Evaluation of fatigue in U.S. patients with primary biliary cirrhosis.
    Am J Gastroenterol, 100(5): 1104-9. [Abstract] [Full-text]
29. Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.
    Ann Pharmacother, 39(5): 908-12. [Abstract] [Full-text]
30. Glucocorticosteroids for primary biliary cirrhosis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
31. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
32. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
33. Orthotopic liver transplantation for Byler's disease.
    Transplant Proc, 37(2): 1149-50. [Abstract] [Full-text]
34. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.
    Transplant Proc, 37(2): 1104-7. [Abstract] [Full-text]
35. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
    Hepatology, 41(5): 1046-55. [Abstract] [Full-text]
36. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
    Hepatology, 41(5): 995-1003. [Abstract] [Full-text]
37. Schistosomal hepatic fibrosis and the interferon gamma receptor: a linkage analysis using single-nucleotide polymorphic markers.
    Eur J Hum Genet, 13(5): 660-8. [Abstract] [Full-text]
38. Successful off-pump pericardiectomy and coronary artery bypass in liver cirrhosis.
    J Card Surg, 20(3): 284-6. [Abstract] [Full-text]
39. Multiple hypervascular liver nodules in a heavy drinker of alcohol.
    J Gastroenterol Hepatol, 20(5): 795-9. [Abstract] [Full-text]
40. Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
    Basic Clin Pharmacol Toxicol, 96(5): 375-80. [Abstract] [Full-text]
41. Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection.
    Genes Immun, 6(3): 242-7. [Abstract] [Full-text]
42. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C.
    Digestion, 71(2): 124-30. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.